An aldose reductase inhibitor reverses early diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense.

The FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Volumn 16, Issue 1, 2002, Pages 123-125

  Obrosova, Irina G ^a   Van Huysen, Carol ^a   Fathallah, Lamia ^a   Cao, Xianghui Cao ^a   Greene, Douglas A ^a   Stevens, Martin J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE REDUCTASE; ANTIOXIDANT; ENZYME INHIBITOR; IMIDAZOLE DERIVATIVE; IMIDAZOLIDINE DERIVATIVE; NICOTINAMIDE ADENINE DINUCLEOTIDE; SORBINIL;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; CYTOSOL; DIABETIC NEUROPATHY; DRUG ANTAGONISM; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; LIPID PEROXIDATION; METABOLISM; MITOCHONDRION; NERVE CONDUCTION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PERIPHERAL NERVE; RAT;

ALDEHYDE REDUCTASE; ANIMALS; ANTIOXIDANTS; CYTOSOL; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; ENZYME INHIBITORS; IMIDAZOLES; IMIDAZOLIDINES; LIPID PEROXIDATION; MITOCHONDRIA; MODELS, BIOLOGICAL; NAD; NEURAL CONDUCTION; OXIDATION-REDUCTION; OXIDATIVE STRESS; PERIPHERAL NERVES; RATS;

EID: 0036357657     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.01-0603fje     Document Type: Article

References (0)